Founder, Origami Innovations
Matthew Erlendson is an MD candidate at the Yale School of Medicine and is a recipient of The Professor David Berg Leadership Scholarship from the Yale School of Management MBA program. He is the founder of Origami Innovations, an innovation, design, and solution lab powered by Yale University students. He is a sitting Executive Board Member and was the Founding Team Leader of Stanford Medicine X, a Silicon Valley based, Stanford University health care innovation hub focused on the intersection of emerging technology and patient-centered design. He has worked by invitation with The White House Office of Science and Technology Policy on President Obama’s Precision Medicine Initiative and his research spans clinical trials, integrating emerging technologies into medicine, and health care policy.